371 related articles for article (PubMed ID: 19615802)
1. Epithelial-mesenchymal transition as a potential explanation for podocyte depletion in diabetic nephropathy.
Yamaguchi Y; Iwano M; Suzuki D; Nakatani K; Kimura K; Harada K; Kubo A; Akai Y; Toyoda M; Kanauchi M; Neilson EG; Saito Y
Am J Kidney Dis; 2009 Oct; 54(4):653-64. PubMed ID: 19615802
[TBL] [Abstract][Full Text] [Related]
2. Epithelial-mesenchymal transition and podocyte loss in diabetic kidney disease.
Reidy K; Susztak K
Am J Kidney Dis; 2009 Oct; 54(4):590-3. PubMed ID: 19781451
[No Abstract] [Full Text] [Related]
3. Clinical significance of fibroblast-specific protein-1 expression on podocytes in patients with focal segmental glomerulosclerosis.
Samejima K; Nakatani K; Suzuki D; Asai O; Sakan H; Yoshimoto S; Yamaguchi Y; Matsui M; Akai Y; Toyoda M; Iwano M; Saito Y
Nephron Clin Pract; 2012; 120(1):c1-7. PubMed ID: 22126861
[TBL] [Abstract][Full Text] [Related]
4. Evaluation of podocyte lesion in patients with diabetic nephropathy: Wilms' tumor-1 protein used as a podocyte marker.
Su J; Li SJ; Chen ZH; Zeng CH; Zhou H; Li LS; Liu ZH
Diabetes Res Clin Pract; 2010 Feb; 87(2):167-75. PubMed ID: 19969384
[TBL] [Abstract][Full Text] [Related]
5. Critical role of serum response factor in podocyte epithelial-mesenchymal transition of diabetic nephropathy.
Zhao L; Wang X; Sun L; Nie H; Liu X; Chen Z; Guan G
Diab Vasc Dis Res; 2016 Jan; 13(1):81-92. PubMed ID: 26408645
[TBL] [Abstract][Full Text] [Related]
6. Podocyte detachment and reduced glomerular capillary endothelial fenestration promote kidney disease in type 2 diabetic nephropathy.
Weil EJ; Lemley KV; Mason CC; Yee B; Jones LI; Blouch K; Lovato T; Richardson M; Myers BD; Nelson RG
Kidney Int; 2012 Nov; 82(9):1010-7. PubMed ID: 22718189
[TBL] [Abstract][Full Text] [Related]
7. Protection of CTGF Antibody Against Diabetic Nephropathy in Mice Via Reducing Glomerular β-Catenin Expression and Podocyte Epithelial-Mesenchymal Transition.
Dai HY; Ma LN; Cao Y; Chen XL; Shi H; Fan YP; Yang B
J Cell Biochem; 2017 Nov; 118(11):3706-3712. PubMed ID: 28370212
[TBL] [Abstract][Full Text] [Related]
8. IGFBP-1 expression is reduced in human type 2 diabetic glomeruli and modulates β1-integrin/FAK signalling in human podocytes.
Lay AC; Hale LJ; Stowell-Connolly H; Pope RJP; Nair V; Ju W; Marquez E; Rollason R; Hurcombe JA; Hayes B; Roberts T; Gillam L; Allington J; Nelson RG; Kretzler M; Holly JMP; Perks CM; McArdle CA; Welsh GI; Coward RJM
Diabetologia; 2021 Jul; 64(7):1690-1702. PubMed ID: 33758952
[TBL] [Abstract][Full Text] [Related]
9. Upregulation of α3β1-Integrin in Podocytes in Early-Stage Diabetic Nephropathy.
Sawada K; Toyoda M; Kaneyama N; Shiraiwa S; Moriya H; Miyatake H; Tanaka E; Yamamoto N; Miyauchi M; Kimura M; Wada T; Fukagawa M
J Diabetes Res; 2016; 2016():9265074. PubMed ID: 27340677
[TBL] [Abstract][Full Text] [Related]
10. Mangiferin prevents diabetic nephropathy progression and protects podocyte function via autophagy in diabetic rat glomeruli.
Wang X; Gao L; Lin H; Song J; Wang J; Yin Y; Zhao J; Xu X; Li Z; Li L
Eur J Pharmacol; 2018 Apr; 824():170-178. PubMed ID: 29444469
[TBL] [Abstract][Full Text] [Related]
11. Intraglomerular crosstalk elaborately regulates podocyte injury and repair in diabetic patients: insights from a 3D multiscale modeling study.
Tan H; Yi H; Zhao W; Ma JX; Zhang Y; Zhou X
Oncotarget; 2016 Nov; 7(45):73130-73146. PubMed ID: 27683034
[TBL] [Abstract][Full Text] [Related]
12. Redistribution of connexin43 expression in glomerular podocytes predicts poor renal prognosis in patients with type 2 diabetes and overt nephropathy.
Sawai K; Mukoyama M; Mori K; Yokoi H; Koshikawa M; Yoshioka T; Takeda R; Sugawara A; Kuwahara T; Saleem MA; Ogawa O; Nakao K
Nephrol Dial Transplant; 2006 Sep; 21(9):2472-7. PubMed ID: 16820374
[TBL] [Abstract][Full Text] [Related]
13. Expression of cholecystokinin-1 receptor is correlated with proteinuria in human diabetic nephropathy.
Wang M; Xie R; Liu R; Jia X; Bao Y; Liu X
Endocrine; 2012 Oct; 42(2):329-34. PubMed ID: 22396142
[TBL] [Abstract][Full Text] [Related]
14. Claudin 1 and nephrin label cellular crescents in diabetic glomerulosclerosis.
Gaut JP; Hoshi M; Jain S; Liapis H
Hum Pathol; 2014 Mar; 45(3):628-35. PubMed ID: 24529330
[TBL] [Abstract][Full Text] [Related]
15. Apoptosis occurs differentially according to glomerular size in diabetic kidney disease.
Jung DS; Lee SH; Kwak SJ; Li JJ; Kim DH; Nam BY; Kang HY; Chang TI; Park JT; Han SH; Yoo TH; Kang SW
Nephrol Dial Transplant; 2012 Jan; 27(1):259-66. PubMed ID: 21652547
[TBL] [Abstract][Full Text] [Related]
16. Glycogen synthase kinase 3β hyperactivity in urinary exfoliated cells predicts progression of diabetic kidney disease.
Liang X; Wang P; Chen B; Ge Y; Gong AY; Flickinger B; Malhotra DK; Wang LJ; Dworkin LD; Liu Z; Gong R
Kidney Int; 2020 Jan; 97(1):175-192. PubMed ID: 31791666
[TBL] [Abstract][Full Text] [Related]
17. Urinary excretion of podocytes in patients with diabetic nephropathy.
Nakamura T; Ushiyama C; Suzuki S; Hara M; Shimada N; Ebihara I; Koide H
Nephrol Dial Transplant; 2000 Sep; 15(9):1379-83. PubMed ID: 10978394
[TBL] [Abstract][Full Text] [Related]
18. Epithelial-to-mesenchymal transition is a potential pathway leading to podocyte dysfunction and proteinuria.
Li Y; Kang YS; Dai C; Kiss LP; Wen X; Liu Y
Am J Pathol; 2008 Feb; 172(2):299-308. PubMed ID: 18202193
[TBL] [Abstract][Full Text] [Related]
19. Intra-renal and urinary mRNA expression of podocyte-associated molecules for the estimation of glomerular podocyte loss.
Wang G; Lai FM; Lai KB; Chow KM; Kwan BC; Li KT; Szeto CC
Ren Fail; 2010 Jan; 32(3):372-9. PubMed ID: 20370455
[TBL] [Abstract][Full Text] [Related]
20. Impaired Podocyte Autophagy Exacerbates Proteinuria in Diabetic Nephropathy.
Tagawa A; Yasuda M; Kume S; Yamahara K; Nakazawa J; Chin-Kanasaki M; Araki H; Araki S; Koya D; Asanuma K; Kim EH; Haneda M; Kajiwara N; Hayashi K; Ohashi H; Ugi S; Maegawa H; Uzu T
Diabetes; 2016 Mar; 65(3):755-67. PubMed ID: 26384385
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
